Tbilisi (GBC) – The Georgian government has decided to allow wholesalers of pharmaceutical products to sell their existing stocks before the expiration date. The change was made in Resolution No. 114 of March 4, 2022, lifting the previous restriction that was to come into effect on April 1 of this year.

According to the regulation, the submission of a document confirming the GMP (Good Manufacturing Practice) standard for pharmaceutical products has become mandatory since October last year. Retailers were given until April 1, 2026, to sell off their stocks, but the business sector was unable to fully sell their stocks within the established timeframe.

Business Arguments and New Deadlines According to the Pharmacists Association, based on consultations with the relevant ministry, the government has taken into account the challenge facing the sector. Under the new resolution, retail and wholesale sales (except for imports) of products whose registration was suspended due to lack of GMP standards are permitted until their expiration date.

“Business was unable to sell the remaining products during this period, which is why we appealed to the Ministry and the government changed the decision,” the Pharmacists Association said.

Tightening of GMP standards

Despite the exemption for the sale of remaining products, the rules for registering pharmaceutical products in Georgia are becoming stricter:

  • From October 1, 2025: Any medicine that undergoes registration or re-registration must have a document of compliance with the European GMP standard.
  • Scope of the requirement: The standard applies to both the final product and the substances used to manufacture it.
  • Obligation: Compliance with this rule is mandatory for both local manufacturers and distributors.

According to experts, the reform aims to bring the quality control of medicines on the market closer to European standards, although allowing the sale of surpluses during the transitional period will protect businesses from significant financial losses.